Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.

Epidemiological studies suggest that mushroom intake is inversely correlated with gastric, gastrointestinal and breast cancers. We have recently demonstrated anticancer and anti-inflammatory activity of triterpene extract isolated from mushroom Ganoderma lucidum (GLT). The aim of the present study w...

Full description

Bibliographic Details
Main Authors: Daniel Sliva, Jagadish Loganathan, Jiahua Jiang, Andrej Jedinak, John G Lamb, Colin Terry, Lee Ann Baldridge, Jiri Adamec, George E Sandusky, Shailesh Dudhgaonkar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3484149?pdf=render
id doaj-f64edd40747d47a283f75487da08386f
record_format Article
spelling doaj-f64edd40747d47a283f75487da08386f2020-11-25T01:53:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4787310.1371/journal.pone.0047873Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.Daniel SlivaJagadish LoganathanJiahua JiangAndrej JedinakJohn G LambColin TerryLee Ann BaldridgeJiri AdamecGeorge E SanduskyShailesh DudhgaonkarEpidemiological studies suggest that mushroom intake is inversely correlated with gastric, gastrointestinal and breast cancers. We have recently demonstrated anticancer and anti-inflammatory activity of triterpene extract isolated from mushroom Ganoderma lucidum (GLT). The aim of the present study was to evaluate whether GLT prevents colitis-associated carcinogenesis in mice.Colon carcinogenesis was induced by the food-borne carcinogen (2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine [PhIP]) and inflammation (dextran sodium sulfate [DSS]) in mice. Mice were treated with 0, 100, 300 and 500 mg GLT/kg of body weight 3 times per week for 4 months. Cell proliferation, expression of cyclin D1 and COX-2 and macrophage infiltration was assessed by immunohistochemistry. The effect of GLT on XRE/AhR, PXR and rPXR was evaluated by the reporter gene assays. Expression of metabolizing enzymes CYP1A2, CYP3A1 and CYP3A4 in colon tissue was determined by immunohistochemistry. GLT treatment significantly suppressed focal hyperplasia, aberrant crypt foci (ACF) formation and tumor formation in mice exposed to PhIP/DSS. The anti-proliferative effects of GLT were further confirmed by the decreased staining with Ki-67 in colon tissues. PhIP/DSS-induced colon inflammation was demonstrated by the significant shortening of the large intestine and macrophage infiltrations, whereas GLT treatment prevented the shortening of colon lengths, and reduced infiltration of macrophages in colon tissue. GLT treatment also significantly down-regulated PhIP/DSS-dependent expression of cyclin D1, COX-2, CYP1A2 and CYP3A4 in colon tissue.Our data suggest that GLT could be considered as an alternative dietary approach for the prevention of colitis-associated cancer.http://europepmc.org/articles/PMC3484149?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Daniel Sliva
Jagadish Loganathan
Jiahua Jiang
Andrej Jedinak
John G Lamb
Colin Terry
Lee Ann Baldridge
Jiri Adamec
George E Sandusky
Shailesh Dudhgaonkar
spellingShingle Daniel Sliva
Jagadish Loganathan
Jiahua Jiang
Andrej Jedinak
John G Lamb
Colin Terry
Lee Ann Baldridge
Jiri Adamec
George E Sandusky
Shailesh Dudhgaonkar
Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
PLoS ONE
author_facet Daniel Sliva
Jagadish Loganathan
Jiahua Jiang
Andrej Jedinak
John G Lamb
Colin Terry
Lee Ann Baldridge
Jiri Adamec
George E Sandusky
Shailesh Dudhgaonkar
author_sort Daniel Sliva
title Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
title_short Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
title_full Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
title_fullStr Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
title_full_unstemmed Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
title_sort mushroom ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Epidemiological studies suggest that mushroom intake is inversely correlated with gastric, gastrointestinal and breast cancers. We have recently demonstrated anticancer and anti-inflammatory activity of triterpene extract isolated from mushroom Ganoderma lucidum (GLT). The aim of the present study was to evaluate whether GLT prevents colitis-associated carcinogenesis in mice.Colon carcinogenesis was induced by the food-borne carcinogen (2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine [PhIP]) and inflammation (dextran sodium sulfate [DSS]) in mice. Mice were treated with 0, 100, 300 and 500 mg GLT/kg of body weight 3 times per week for 4 months. Cell proliferation, expression of cyclin D1 and COX-2 and macrophage infiltration was assessed by immunohistochemistry. The effect of GLT on XRE/AhR, PXR and rPXR was evaluated by the reporter gene assays. Expression of metabolizing enzymes CYP1A2, CYP3A1 and CYP3A4 in colon tissue was determined by immunohistochemistry. GLT treatment significantly suppressed focal hyperplasia, aberrant crypt foci (ACF) formation and tumor formation in mice exposed to PhIP/DSS. The anti-proliferative effects of GLT were further confirmed by the decreased staining with Ki-67 in colon tissues. PhIP/DSS-induced colon inflammation was demonstrated by the significant shortening of the large intestine and macrophage infiltrations, whereas GLT treatment prevented the shortening of colon lengths, and reduced infiltration of macrophages in colon tissue. GLT treatment also significantly down-regulated PhIP/DSS-dependent expression of cyclin D1, COX-2, CYP1A2 and CYP3A4 in colon tissue.Our data suggest that GLT could be considered as an alternative dietary approach for the prevention of colitis-associated cancer.
url http://europepmc.org/articles/PMC3484149?pdf=render
work_keys_str_mv AT danielsliva mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT jagadishloganathan mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT jiahuajiang mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT andrejjedinak mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT johnglamb mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT colinterry mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT leeannbaldridge mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT jiriadamec mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT georgeesandusky mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
AT shaileshdudhgaonkar mushroomganodermalucidumpreventscolitisassociatedcarcinogenesisinmice
_version_ 1724990664632958976